Doctors Deploy Antibody Drugs Against COVID-19 And Hope Effort's Worthwhile
Posted on AllSides November 25th, 2020
From The Left
More than 2,400 hospitals and related facilities have received their first doses of new drugs that are designed to keep mild to moderately ill COVID-19 patients out of the hospital. But it's not clear how much the drugs will help these patients – and whether the medicines will reduce the demand for hospital beds.
The Food and Drug Administration has granted emergency authorization to two monoclonal antibody formulations – bamlanivimab, produced by Eli Lilly, and a two-antibody combination developed by Regeneron.
These drugs are supposed to prevent the coronavirus from...
AllSides Media Bias Rating: Lean Left
